Sandoz launches generic copies of TIAZAC (diltiazem HCL) ER capsules in the US

Sandoz today announced the US launch of diltiazem HCL ER capsules, USP, a generic version of Forest Labs’ TIAZAC®.Diltiazem HCL ER capsules are indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive medications. It is also indicated for the treatment of chronic stable angina.

According to IMS Health, US sales for branded and generic versions of diltiazem HCL ER capsules were approximately USD 174 million for the calendar year 2012. Sandoz is marketing diltiazem ER capsules in the 120 mg, 180 mg, 240 mg, 300 mg, 360 mg, and 420 mg strengths, the same strengths that are marketed as TIAZAC

Enter your email address:


Delivered by FeedBurner